Glaucoma Portugal Screening Trial
Launched by CENTRO HOSPITALAR UNIVERSITÁRIO LISBOA NORTE · May 16, 2023
Trial Information
Current as of May 08, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Glaucoma diagnosis is currently based on opportunistic case finding, which makes the case for up to 50% of patients remaining undiagnosed. Diagnostic technology has been deemed efficient in diagnosing, but cost and (hospital) location acts as a barrier for effective screening for this asymptomatic disease with a low population-based prevalence
Portuguese National Strategy for Visual Health, published in 2018 asks for a pilot study aimed at a one-time intervention at the primary care setting at the age of 60 years to do both an optic disc analysis and an intraocular pressure (IOP) measureme...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subjects age between 55 to 65 years old registered in the primary care area of either ACES Lisbon Norte (Lisbon arm) or in the area of ACES Alto Minho (Minho arm)
- • willingness to sign an informed consent for the screening process
- Exclusion Criteria:
- • - none
- • Poor quality in screening image will be included in the intention to treat analysis, but excluded from the diagnostic comparator outcome.
- • Patients with a known glaucoma diagnosis will not be excluded from the screening
About Centro Hospitalar Universitário Lisboa Norte
Centro Hospitalar Universitário Lisboa Norte (CHULN) is a leading academic medical center in Portugal, dedicated to advancing healthcare through innovative clinical research. As a prominent sponsor of clinical trials, CHULN integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations that enhance patient care and contribute to medical knowledge. With a multidisciplinary team of healthcare professionals and researchers, CHULN emphasizes ethical standards and regulatory compliance in its research initiatives, aiming to improve treatment outcomes and develop new therapeutic options for a wide range of conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lisbon, , Portugal
Lisbon, , Portugal
Viana Do Castelo, , Portugal
Patients applied
Trial Officials
Luis Abegão Pinto, MD, PhD
Study Chair
Centro Hospitalar Universitário Lisboa Norte
Sérgio Azevedo, MD
Study Chair
Unidade Local Saude Alto Minho
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported